DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Poland
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
BIO logo

BIOTON S.A. Stock Price

WSE:BIO Community·zł302.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

BIO Share Price Performance

zł0
-4.49 (-100.00%)
​
zł0
-4.49 (-100.00%)
​
Price zł0
Thu, 17 Sep 26
Share Pricen/a

BIO Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with low risk.

3 Risks
0 Rewards
View Full Analysis

BIOTON S.A. Key Details

zł257.2m

Revenue

zł161.8m

Cost of Revenue

zł95.4m

Gross Profit

zł103.8m

Other Expenses

-zł8.4m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Nov 10, 2026
-0.097
37.11%
-3.25%
8.3%
View Full Analysis

About BIO

Founded
1989
Employees
363
CEO
Jeremy Launders
WebsiteView website
www.bioton.pl

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; and oral diabetic drugs.BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.

Recent BIO News & Updates

Recent updates

No updates

BIOTON S.A. Competitors

CLN logo

Celon Pharma

Symbol: WSE:CLN
Market cap: zł1.2b
SLV logo

Selvita

Symbol: WSE:SLV
Market cap: zł477.2m
CTX logo

Captor Therapeutics Spolka Akcyjna

Symbol: WSE:CTX
Market cap: zł460.0m
BCX logo

Bioceltix

Symbol: WSE:BCX
Market cap: zł417.1m
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide